XML 61 R46.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation - Additional Information (Details)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 11, 2022
shares
Dec. 31, 2021
shares
Mar. 31, 2022
USD ($)
plan
shares
Mar. 31, 2017
shares
Dec. 31, 2019
shares
Dec. 31, 2018
shares
Dec. 31, 2017
shares
Dec. 31, 2016
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Equity compensation plan, number of plans | plan     3          
Additional awards granted (in shares)     673,888          
Outstanding stock options                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Unrecognized compensation expense | $     $ 18.0          
Weighted-average remaining vesting period     2 years 6 months          
Non-vested restricted stock awards                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Unrecognized compensation expense related to unvested awards | $     $ 12.0          
Weighted-average of remaining vesting period     2 years 9 months 18 days          
Granted (in shares)     347,814          
Non-vested restricted stock awards | Minimum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock-based awards, vesting period     1 year          
Non-vested restricted stock awards | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock-based awards, vesting period     4 years          
Restricted Stock With Non-Market Performance Conditions                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Granted (in shares)     218,418       98,817  
Restricted Stock Units (RSUs)                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Unrecognized compensation expense related to unvested awards | $     $ 2.8          
Weighted-average of remaining vesting period     2 years 9 months 18 days          
Granted (in shares)     1,989          
2005 Aerie Pharmaceutical Stock Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Additional awards granted (in shares)     0          
2013 Omnibus incentive plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of shares authorized (in shares)   10,229,068            
Additional shares authorized (in shares)           4,500,000    
Inducement Award Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of shares authorized (in shares) 4,092,500             418,000
Additional shares authorized (in shares)       874,500 100,000      
Inducement Award Plan | Chief Executive Officer                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Granted (in shares)   602,952            
Amended And Restated Omnibus Incentive Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Additional shares authorized (in shares) 2,097,048